Stefan Sleijfer

Stefan Sleijfer

UNVERIFIED PROFILE

Are you Stefan Sleijfer?   Register this Author

Register author
Stefan Sleijfer

Stefan Sleijfer

Publications by authors named "Stefan Sleijfer"

Are you Stefan Sleijfer?   Register this Author

100Publications

2829Reads

37Profile Views

Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors.

Pharmacogenomics J 2019 Oct 4;19(5):473-479. Epub 2019 Feb 4.

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41397-019-0079-zDOI Listing
October 2019

Incorporating liquid biopsies into treatment decision-making: obstacles and possibilities.

Drug Discov Today 2019 Sep 3;24(9):1715-1719. Epub 2019 Jun 3.

Erasmus MC Cancer Institute, Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2019.05.028DOI Listing
September 2019

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.

Int J Cancer 2019 Aug 27;145(4):1083-1089. Epub 2019 Feb 27.

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32209DOI Listing
August 2019

Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.

Breast Cancer Res Treat 2019 Jun 13;175(2):451-458. Epub 2019 Feb 13.

Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05141-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533419PMC
June 2019

Natural history of well-differentiated liposarcoma of the extremity compared to patients treated with surgery.

Surg Oncol 2019 Jun 9;29:84-89. Epub 2019 Apr 9.

Department of Surgical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015GD, Rotterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suronc.2019.04.004DOI Listing
June 2019

The role of mitochondrial DNA in breast tumors.

Drug Discov Today 2019 05 22;24(5):1202-1208. Epub 2019 Mar 22.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2019.03.019DOI Listing
May 2019

Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review.

Front Oncol 2019 17;9:397. Epub 2019 May 17.

Department of Medical Oncology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534064PMC
May 2019

Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.

Eur J Surg Oncol 2019 04 18;45(4):691-698. Epub 2018 Oct 18.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center Rotterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07487983183143
Publisher Site
http://dx.doi.org/10.1016/j.ejso.2018.09.019DOI Listing
April 2019

Novel methods to diagnose leptomeningeal metastases in breast cancer.

Neuro Oncol 2019 Mar;21(4):428-439

Erasmus MC Cancer Institute, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noy186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422430PMC
March 2019

An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA.

J Mol Diagn 2019 Jan 6;21(1):123-137. Epub 2018 Oct 6.

Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2018.08.010DOI Listing
January 2019

Self-Seeding Microwells to Isolate and Assess the Viability of Single Circulating Tumor Cells.

Int J Mol Sci 2019 Jan 23;20(3). Epub 2019 Jan 23.

Medical Cell BioPhysics, University of Twente, Hallenweg 23, 7522 NH Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20030477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387105PMC
January 2019

Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers.

Cancers (Basel) 2018 Dec 9;10(12). Epub 2018 Dec 9.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10120500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318759PMC
December 2018

Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatment.

Support Care Cancer 2018 Jun 15;26(6):1781-1789. Epub 2017 Dec 15.

Department of Internal Medicine, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, 3318, Dordrecht, AT, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-4018-8DOI Listing
June 2018

Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.

Clin Cancer Res 2018 06 6;24(11):2678-2687. Epub 2018 Mar 6.

Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3512DOI Listing
June 2018

Evidence on the cost of breast cancer drugs is required for rational decision making.

Ecancermedicalscience 2018 16;12:825. Epub 2018 Apr 16.

Health Technology and Services Research, University of Twente, 7500 AE Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2018.825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931813PMC
April 2018

Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out.

J Clin Oncol 2018 03 1;36(9):837-840. Epub 2018 Feb 1.

Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5610DOI Listing
March 2018

Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer.

Breast Cancer Res Treat 2018 Feb 17;168(1):95-105. Epub 2017 Nov 17.

Department of Internal Medicine, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, 3318 AT, Dordrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4574-0DOI Listing
February 2018

EJC's biennial report on metastatic soft tissue sarcoma: State of the art and future perspectives.

Eur J Cancer 2018 01 1;88:87-91. Epub 2017 Dec 1.

Department of Medical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.10.020DOI Listing
January 2018

Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.

Cell Oncol (Dordr) 2017 Oct 2;40(5):511-519. Epub 2017 Jun 2.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-017-0327-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608799PMC
October 2017

Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.

PLoS One 2017 15;12(8):e0183155. Epub 2017 Aug 15.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183155PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557548PMC
October 2017

Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy.

Clin Cancer Res 2017 Aug 18;23(16):4735-4743. Epub 2017 Apr 18.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0032DOI Listing
August 2017

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.

J Clin Oncol 2017 May 31;35(15):1713-1720. Epub 2017 Mar 31.

Paolo G. Casali, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori and University of Milan; Elena Fumagalli and Alessandro Gronchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milano, Italy; John Zalcberg, Peter MacCallum Cancer Institute, East Melbourne, Victoria; Dusan Kotasek, Adelaide Cancer Centre, Kurralta Park and University of Adelaide, South Australia, Australia; Axel Le Cesne, Gustave Roussy, Villejuif; Jean-Yves Blay, NetSARC and Site de Recherche Intégrée sur le Cancer de Lyon, Centre Leon Berard, Lyon; Antoine Italiano, Institut Bergonie, Bordeaux, France; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Lars H. Lindner, Klinikum der Universitaet München, München; Viktor Grünwald, School Hannover, Hannover, Germany; Ian R. Judson and Winette van der Graaf, Royal Marsden Hospital, London, United Kingdom; Patrick Schöffski, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Leuven; Saskia Litière and Sandrine Marreaud, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Serge Leyvraz, University Hospital, Lausanne, Switzerland; Antonio Lopez Pousa, Hospital De La Santa Creu I Sant Pau, Barcelona, Spain; Stefan Sleijfer and Jaap Verweij, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam; Jan M. Kerst, The Netherlands Cancer Institute, Amsterdam; Pancras Hogendoorn, Leiden University Medical Center, Leiden; Winette van der Graaf, Radboud University, Medical Center Nijmegen, the Netherlands; and Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.0228
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.0228DOI Listing
May 2017

Identification of microRNA biomarkers for response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial.

Eur J Cancer 2017 04 16;75:33-40. Epub 2017 Feb 16.

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.018DOI Listing
April 2017

Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure.

Clin Pharmacokinet 2017 03;56(3):305-310

Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-016-0441-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315737PMC
March 2017

Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy.

Breast 2017 Feb 27;31:9-15. Epub 2016 Oct 27.

Department of Internal Medicine, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, 3318 AT, Dordrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2016.10.014DOI Listing
February 2017

ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients.

Cancer Treat Rev 2017 Jan 10;52:33-40. Epub 2016 Nov 10.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.11.001DOI Listing
January 2017

T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients.

Front Immunol 2016 26;7:648. Epub 2016 Dec 26.

Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC-Cancer Institute , Rotterdam , Netherlands.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fimmu.2016.00
Publisher Site
http://dx.doi.org/10.3389/fimmu.2016.00648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183620PMC
December 2016

The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.

Oncologist 2016 Nov 13;21(11):1396-1409. Epub 2016 Jul 13.

Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189631PMC
November 2016

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.

Neoplasia 2016 Nov 17;18(11):647-653. Epub 2016 Oct 17.

Erasmus MC Cancer Institute, Erasmus University Medical Center, Department of Medical Oncology and Cancer Genomics Netherlands, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071539PMC
November 2016

Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based Registry.

Urology 2016 Sep 11;95:121-7. Epub 2016 May 11.

Institute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.04.042DOI Listing
September 2016

MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses.

J Immunol 2016 09 3;197(6):2541-52. Epub 2016 Aug 3.

Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, the Netherlands; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1502024DOI Listing
September 2016

Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cells.

Clin Immunol 2016 08 1;169:107-113. Epub 2016 Jul 1.

Laboratory of Tumor Immunology, Erasmus MC-Cancer Institute, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2016.06.014DOI Listing
August 2016

Health policy: Affordability of drugs used in oncology health care.

Nat Rev Clin Oncol 2016 06 10;13(6):331-2. Epub 2016 May 10.

Faculty of Medicine and Health Sciences, Erasmus MC, PO Box 2040, 3000 CA, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.77DOI Listing
June 2016

Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview.

Biochem Soc Trans 2016 Jun;44(3):951-9

Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC-Cancer Institute, 3015 CN Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BST20160037DOI Listing
June 2016

Pazopanib for patients with advanced soft tissue sarcomas in a real-life setting.

Authors:
Stefan Sleijfer

Cancer 2016 05 11;122(9):1346-8. Epub 2016 Mar 11.

Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29963DOI Listing
May 2016

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.

Oncotarget 2016 May;7(20):29166-76

Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045386PMC
May 2016

The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer.

Cancer Treat Rev 2016 May 12;46:42-50. Epub 2016 Apr 12.

Erasmus MC Cancer Institute, Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.04.001DOI Listing
May 2016

Adoptive T-cell therapy: a need for standard immune monitoring.

Immunotherapy 2015 ;7(5):513-33

Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.15.23DOI Listing
March 2016

Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment.

Eur J Cancer 2016 Mar 1;56:101-106. Epub 2016 Feb 1.

Dept of Medical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.12.019DOI Listing
March 2016

Development and validation of an UPLC-MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair.

J Pharm Biomed Anal 2015 Oct 12;114:416-25. Epub 2015 Jun 12.

Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2015.06.018DOI Listing
October 2015

Lysosomal Sequestration Determines Intracellular Imatinib Levels.

Mol Pharmacol 2015 Sep 24;88(3):477-87. Epub 2015 Jun 24.

Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (H.B., A.T.D., S.Se., A.W.M.B., P.B., S.Sl., R.H.J.M., E.A.C.W.); Department of Human Genetics, Catholic University Leuven and University Hospitals, Leuven, Belgium (M.D.-R.); Division of Human Health and Medical Science, Graduate School of Kuroshio Science, Kochi University, Nankoku, Kochi, Japan (T.T.); and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (A.S.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.114.097451DOI Listing
September 2015

Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With Sunitinib.

Hypertension 2015 Sep 20;66(3):543-9. Epub 2015 Jul 20.

From the Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands (S.L., M.H.W.K., F.M.M.S., A.H.J.D., A.H.v.d.M.); Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (H.J.B.); Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands (M.H.W.K.); Department of Pathology, Reinier de Graaf Gasthuis, Delft, The Netherlands (F.M.M.S.); Department of Pathology, Herlev University Hospital, Herlev, Denmark (A.H.); Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands (M.C.C.-v.G.); and Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands (S.S., R.H.JM.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.05435DOI Listing
September 2015

Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.

J Clin Pharmacol 2015 Aug 6;55(8):920-5. Epub 2015 May 6.

Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.498DOI Listing
August 2015

Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation.

Haematologica 2015 Jun 20;100(6):e246-9. Epub 2015 Feb 20.

Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.121731DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450641PMC
June 2015

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Mol Oncol 2015 Apr 21;9(4):920-32. Epub 2015 Jan 21.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528769PMC
April 2015

Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2-positive breast cancer?

J Clin Oncol 2015 Mar 20;33(7):673-5. Epub 2015 Jan 20.

Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.5058DOI Listing
March 2015

Circulating tumor cell enumeration by the CellSearch system: the clinician's guide to breast cancer treatment?

Cancer Treat Rev 2015 Feb 23;41(2):144-50. Epub 2014 Dec 23.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.12.008DOI Listing
February 2015